Russell Kitch, MD
Otolaryngology · North Charleston, SCNPI 1992705099
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.1%), travel and lodging and education — rather than concentrated in one kind of arrangement. Inspire Medical Systems, Inc. accounts for 61.2% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2023 at $1,777 and has fallen 79.4% since, to $366 in 2025.
Across 53 payments — averaging $47.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$2K
- Regeneron Healthcare Solutions, Inc.$272
- GSK$237
- Sanofi$95
- Optinose US, Inc.$93
- Organogenesis Inc.$77
- plus $211 from 10 others
What the payments were for
- Travel & lodging$1,22648%
- Food & beverage$1,24949%
- Education$663%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 13 | $1,555 |
| Regeneron Healthcare Solutions, Inc. | 8 | $272 |
| GSK | 12 | $237 |
| Sanofi | 3 | $95 |
| Optinose US, Inc. | 4 | $93 |
| Organogenesis Inc. | 2 | $77 |
| Stryker | 2 | $35 |
| Merck | 1 | $28 |
| Ambu Inc. | 1 | $26 |
| Pharming Healthcare, Inc. | 1 | $23 |
| Phadia US Inc. | 1 | $20 |
| Medtronic | 1 | $17 |
| Jazz Pharmaceuticals Inc. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Integra Lifesciences Corporation | 1 | $15 |
| Smith+Nephew | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$1,302
How this compares
$2,541 in reported general payments places this provider in the 65th percentile of 180 otolaryngology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 104 | $2,218 |
| Ipratropium Bromide | 32 | $1,513 |
| Famotidine | 78 | $780 |
| Fluocinolone Acetonide Oil | 12 | $466 |
| Omeprazole | 28 | $345 |
| Azelastine Hcl | 15 | $336 |
| Mometasone Furoate | 11 | $113 |
| Pantoprazole Sodium | 20 | $104 |
| Prednisone | 14 | $38 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in North Charleston
- Peter HorwichNorth Charleston$33K
- Shaun NguyenCharleston$973K
- Rodney SchlosserCharleston$382K
- Zachary SolerCharleston$67K
- Eugene BrownCharleston$28K
- Jason NewmanCharleston$26K
- Joshua HornigCharleston$25K
- Ashli OrourkeCharleston$21K
- Alexandra KejnerCharleston$19K
- Evan GraboyesCharleston$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.